Queensland COVID-19 research
This page of Queensland’s research related to the COVID-19 pandemic is compiled from information provided by Queensland universities and research institutes.
While many of our researchers are working on potential vaccines, treatments and other medical interventions, other researchers are applying their expertise to other impacts of the pandemic upon our economy and other aspects of society. The data includes immediate research activity, recent relevant work, proposed research (subject to available funds) and other responses using the resources and expertise of our research organisations.
Listing 1 matching response out of 149 total responses.
Development and translation of epigenetic drugs for infectious diseases including COVID-19 and also heart failure August 2021
A team of QIMR Berghofer researchers lead by A/Prof James Hudson have discovered some of the ways COVID-19 damages the heart. By screening for drugs using human cardiac organoids they have identified a class of drugs that could potentially protect or reverse this cardiac injury. In severe cases of COVID-19, the immune system overreacts to the infection, releasing inflammatory molecules called cytokines into the bloodstream. This so-called ’cytokine storm’ can damage multiple organs, including the heart. Canadian company Resverlogix has used the QIMR Berghofer research findings as the basis for expanding its clinical trial of the drug, apabetalone, in COVID-19 patients. This project is one of several projects enabled by a $5 million funding injection, in 2020, from the Queensland Government.
Other Queensland COVID-19 initiatives
- Queensland Government
- Coronavirus (COVID-19) business assistance finder
- Life Sciences Queensland
- Life Sciences Queensland joins the data-powered alliance to stop COVID-19
Key Australian COVID-19 initiatives
Key international COVID-19 initiatives
- CORD-19 (COVID-19 Open Research Dataset)
- Free database of 130,000 plus COVID-19 open research papers